Fintel reports that on August 21, 2025, JP Morgan downgraded their outlook for Alcon (NYSE:ALC) from Overweight to Neutral.

Alcon (NYSE:ALC) stock continues to decline as J.P. Morgan downgrades the company following mixed Q2 2025 results and lowered sales guidance. Read more here.

H.C. Wainwright upgraded CoreWeave (CRWV) to Buy from Neutral with an $180 price target. The stock's valuation "has sunk deep enough," the analyst tells investors in a research note. Arete also ...

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...

Alcon AG (NYSE:ALC) saw its stock fall more than 2% on Thursday following a rating cut by J.P. Morgan, citing disappointing quarterly performance and reduced visibility on earnings. David Adlington, ...

The analysts cut its rating on Alcon shares to “neutral” from “overweight” and lowered its price target to SFr 62.8 for June 2027, down from SFr 94.7 for June 2026. The reduced target reflects lower ...

On July 30, JPMorgan Chase & Co. (NYSE:JPM) and Coinbase announced a strategic partnership, setting a new standard for customer choice as well as security in the innovation economy.

JPMorgan Chase denied claims that it “debanked” former Kansas Gov. Sam Brownback over his conservative and religious views, according to a report Thursday.

JP Morgan has unveiled its new global structuring management team, which sees multiple senior staff promotions and expanded roles across asset class and cross-asset areas. The new offering is set to ...

JP Morgan Once Told Donald Trump He Has 20 Days To Get Out The president is going to prevent this kind of debanking with an executive order that will punish firms that discriminate against ...

Alcon is building out its portfolio of lens implants, with a $1.5 billion deal to acquire the flagging Staar Surgical and its focus on correcting nearsightedness.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens ...